Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new case may provide clues to help researchers develop strategies for a functional cure.
While the risky procedure is not suitable for most people living with HIV, it offers clues for more feasible approaches.
A new study clarifies the benefits and risks of treatments for those with multiple myeloma, a blood cancer more common in Black Americans.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
The woman’s leukemia is in remission and she remains free of detectable HIV more than a year after stopping antiretroviral treatment.
Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.
Researchers are examining opportunities for immune-modulating approaches to improve outcomes and reduce side effects.
Kellie Smith, 52, lives in Austin with her husband and child. She has multiple myeloma.
Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
Younger adults and stem cell transplant recipients are at highest risk for measles and mumps.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
Some people with blood cancers, however, may not be as well protected.
Rikako Ikee, who competed in the 2016 Olympics at age 16, was diagnosed with leukemia in early 2019, prompting a yearlong hiatus.
The coronavirus vaccines are safe and should be effective even for people with advanced cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.